Effect of denosumab on bone turnover markers in postmenopausal osteoporosis: Initial response and subsequent release from suppression

被引：0
|
作者：
Eastell, R. [1 ]
Austin, M. [2 ]
Martin, J. San [3 ]
McClung, M. R. [4 ]
Christiansen, C. [5 ]
Libanati, C. [3 ]
Siris, E. S. [6 ]
Cummings, S. R. [7 ]
机构：
[1] Univ Sheffield, Acad Unit Bone Metab, Sheffield, S Yorkshire, England
[2] Amgen Inc, Clin Biostat, Thousand Oaks, CA 91320 USA
[3] Amgen Inc, Dept Med, Thousand Oaks, CA 91320 USA
[4] Univ Oregon, Oregon Osteoporosis Ctr, Portland, OR USA
[5] Ctr Clin & Basic Res, Dept Med, Ballerup, Denmark
[6] Columbia Univ, Med Ctr, Dept Med, New York, NY USA
[7] UCSF, Clin Trial Coordinating Ctr, San Francisco, CA USA
来源：
BONE | 2009年 / 44卷 / 02期
关键词：
D O I：
10.1016/j.bone.2009.03.105
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S242 / S243
页数：2
相关论文
共 50 条
  • [1] Effects of Denosumab on Bone Turnover Markers in Postmenopausal Osteoporosis
    Eastell, Richard
    Christiansen, Claus
    Grauer, Andreas
    Kutilek, Stepan
    Libanati, Cesar
    McClung, Michael R.
    Reid, Ian R.
    Resch, Heinrich
    Siris, Ethel
    Uebelhart, Daniel
    Wang, Andrea
    Weryha, Georges
    Cummings, Steve R.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (03) : 530 - 537
  • [2] The Effect of Denosumab on Bone Turnover Markers (BTM) in Postmenopausal Women With Osteoporosis
    Cummings, Steven
    Wang, Andrea
    San Martin, Javier
    McClung, Mike
    Claus, Christiansen
    Libanati, Cesar
    Siris, Ethel
    Eastell, Richard
    BONE, 2010, 46 : S28 - S28
  • [3] Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis
    Sanchez, A.
    Brun, L. R.
    Salerni, H.
    Costanzo, P. R.
    Gonzalez, D.
    Bagur, A.
    Oliveri, B.
    Zanchetta, M. B.
    Farias, V.
    Maffei, L.
    Premrou, V.
    Mansur, J. L.
    Larroude, M. S.
    Sarli, M. A.
    Rey, P.
    Ulla, M. R.
    Pavlove, M. M.
    Karlsbrum, S.
    Brance, M. L.
    JOURNAL OF OSTEOPOROSIS, 2016, 2016
  • [4] Dose–response study of denosumab on bone mineral density and bone turnover markers in Japanese postmenopausal women with osteoporosis
    T. Nakamura
    T. Matsumoto
    T. Sugimoto
    M. Shiraki
    Osteoporosis International, 2012, 23 : 1131 - 1140
  • [5] Dose-response study of denosumab on bone mineral density and bone turnover markers in Japanese postmenopausal women with osteoporosis
    Nakamura, T.
    Matsumoto, T.
    Sugimoto, T.
    Shiraki, M.
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 (03) : 1131 - 1140
  • [6] BONE TURNOVER MARKERS RELATIONS TO POSTMENOPAUSAL OSTEOPOROSIS
    Jovcevska, Jasmina Mecevska
    Stratrova, Slavica Subeska
    Gjorgovski, Icko
    Gruev, Todor
    Kotevska, Mimoza Nikolovska
    Janicevic-Ivanovska, Daniela
    Petrovska, Emilija
    JOURNAL OF MEDICAL BIOCHEMISTRY, 2009, 28 (03) : 161 - 165
  • [7] Use of bone turnover markers in postmenopausal osteoporosis
    Eastell, Richard
    Szulc, Pawel
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (11): : 908 - 923
  • [8] Bone turnover markers in the management of postmenopausal osteoporosis
    Brown, Jacques P.
    Albert, Caroline
    Nassar, Bassam A.
    Adachi, Jonathan D.
    Cole, David
    Davison, K. Shawn
    Dooley, Kent C.
    Don-Wauchope, Andrew
    Douville, Pierre
    Hanley, David A.
    Jamal, Sophie A.
    Josse, Robert
    Kaiser, Stephanie
    Krahn, John
    Krause, Richard
    Kremer, Richard
    Lepage, Raymond
    Letendre, Elaine
    Morin, Suzanne
    Ooi, Daylily S.
    Papaioaonnou, Alexandra
    Ste-Marie, Louis-Georges
    CLINICAL BIOCHEMISTRY, 2009, 42 (10-11) : 929 - 942
  • [9] The use of biochemical markers of bone turnover in postmenopausal osteoporosis
    Delmas, PD
    ANNALES DE BIOLOGIE CLINIQUE, 2001, 59 (03) : 299 - 308
  • [10] Effect of continuous and intermittent nasal calcitonin on bone turnover markers in postmenopausal osteoporosis
    Karadag, A
    Sermez, Y
    Yüksel, D
    Kaptanoglu, B
    OSTEOPOROSIS INTERNATIONAL, 2002, 13 : S46 - S46
12345